A 2025 narrative review evaluates the evidence for cannabinoids in chronic pain management, summarizing modest analgesic benefits, meaningful adverse effects, and the regulatory barriers that limit clinical implementation.
A 2025 narrative review evaluates the evidence for cannabinoids in chronic pain management, summarizing modest analgesic benefits, meaningful adverse effects, and the regulatory barriers that limit clinical implementation.